☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
App
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
COVID-19
The Emergence of Artificial Intelligence in the Pharmaceutical Industry
August 9, 2022
J&J’s Vaccine Booster Dose Increases Antibody & T-cell Responses 6 mos Post BNT162B2 Regimen
December 6, 2021
J&J’s Vaccine Booster Dose Increases Antibody & T-cell Responses 6 mos Post BNT162B2 Regimen
December 6, 2021
AstraZeneca Reports Results of AZD7442 in P-III PROVENT and TACKLE Trial for the Treatment of COVID-19
November 18, 2021
AstraZeneca Reports Results of AZD7442 in P-III PROVENT and TACKLE Trial for the Treatment of COVID-19
November 18, 2021
Merck and Ridgeback Present Results of Molnupiravir in P-III MOVe-OUT Trial for the Treatment of COVID-19 at ASTMH 2021
November 17, 2021
Load more...
Back to Home